Drug Shortage Report for TARO-TEMOZOLOMIDE

Last updated on 2020-02-11 History
Report ID 95531
Drug Identification Number 02443511
Brand name TARO-TEMOZOLOMIDE
Common or Proper name TARO-TEMOZOLOMIDE
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TEMOZOLOMIDE
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 20 blister
ATC code L01AX
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-27
Estimated end date 2020-02-14
Actual end date 2020-02-10
Shortage status Resolved
Updated date 2020-02-11
Company comments
Health Canada comments
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-02-11 French Compare
v10 2020-02-11 English Compare
v9 2020-01-04 French Compare
v8 2020-01-04 English Compare
v7 2019-12-13 French Compare
v6 2019-12-13 English Compare
v5 2019-10-11 French Compare
v4 2019-10-11 English Compare
v3 2019-10-11 English Compare
v2 2019-10-04 French Compare
v1 2019-10-04 English Compare